Cryoprotectant-free vitrification of spermatozoa: Fish as a model of human.


Journal

Andrologia
ISSN: 1439-0272
Titre abrégé: Andrologia
Pays: Germany
ID NLM: 0423506

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 07 06 2018
revised: 03 09 2018
accepted: 07 09 2018
pubmed: 10 10 2018
medline: 24 4 2019
entrez: 10 10 2018
Statut: ppublish

Résumé

Post-thawing motility of spermatozoon, which is directly correlated with the integrity of mitochondrion, is the main parameter for evaluation of respective cryopreservation treatments. In this review, we describe our model of mitochondrial apparatus of spermatozoa and behaviour of this apparatus during cryopreservation. This model shows why a priori the mitochondrial apparatus of the human spermatozoon is expected to be more cryo-stable than the mitochondrial apparatus of the fish spermatozoon. Negative changes of mitochondrial membrane potential are a good indicator of the functional normality of mammalian and fish spermatozoa. It is concluded that the cryostability of mitochondrial membranes of fish spermatozoa is lower than that of human spermatozoa, and protocols for effective cryopreservation of fish spermatozoa can be extrapolated to human spermatozoa. It is also provided a biological explanation for why cryoprotectant-free vitrification for human ejaculates is better than conventional freezing and vitrification with cryoprotectants. This review also includes a description of the various technologies of vitrification of human and fish spermatozoa. For cryobiological investigations, we propose to evaluate the fish spermatozoon as a suitable representative model of the human spermatozoon.

Identifiants

pubmed: 30298523
doi: 10.1111/and.13166
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13166

Subventions

Organisme : Alexander von Humboldt Foundation

Informations de copyright

© 2018 Blackwell Verlag GmbH.

Auteurs

Vladimir Isachenko (V)

Research Group for Reproductive Medicine, Department of Obstetrics and Gynecology, Medical Faculty, Cologne University, Cologne, Germany.

Raul Sanchez (R)

Center of Reproductive Biotechnology - Scientific and Technological Bioresource Nucleus (CEBIOR - BIOREN), Universidad de La Frontera, Temuco, Chile.

Gohar Rahimi (G)

Research Group for Reproductive Medicine, Department of Obstetrics and Gynecology, Medical Faculty, Cologne University, Cologne, Germany.

Peter Mallmann (P)

Research Group for Reproductive Medicine, Department of Obstetrics and Gynecology, Medical Faculty, Cologne University, Cologne, Germany.

Evgenia Isachenko (E)

Research Group for Reproductive Medicine, Department of Obstetrics and Gynecology, Medical Faculty, Cologne University, Cologne, Germany.

Markus Merzenich (M)

MedEvent Dr. Merzenich GmbH, Cologne, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH